# Accel Diagnostics, LLC

Canonical: https://abierto.us/vendors/accel-diagnostics-llc-quj4efck59n4

- UEI: QUJ4EFCK59N4
- CAGE: 5G0E4
- Location: Houston, TX
- Awards in window: 1 (1 transactions), $0 obligated, February 14, 2024 to February 14, 2024

## Awarding agencies

- National Institutes of Health: 1 awards, $0

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $0

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- 75N92019C00002 (definitive contract): $0, National Institutes of Health Nhlbi. SBIR Topic 97 - Phase II - Minimally Invasive Test for Chemotherapy-Induced Cardiotoxicity.. https://www.usaspending.gov/award/CONT_AWD_75N92019C00002_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/accel-diagnostics-llc-quj4efck59n4.